Schedule 13G ownership disclosure
CASI PHARMACEUTICALS INC
Security class unavailable · CUSIP: 14757U109
Event date: 2016-01-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.0300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-089202
- Form type
- SC 13G
- Filer
- CASI Pharmaceuticals, Inc (DE)
- CIK
- CIK 895051
- Filed
- Mar 21, 2016
- Reporting period
- Jan 15, 2016
- Description
- Schedule 13G beneficial ownership